Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia
In the last decade, improvements in genetic testing have revolutionized the molecular diagnosis of inherited thrombocytopenias (ITs), increasing the spectrum of knowledge of these rare, complex and heterogeneous disorders. In contrast, the therapeutic management of ITs has not evolved in the same wa...
Main Authors: | José María Bastida, José Ramón Gonzalez-Porras, José Rivera, María Luisa Lozano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4330 |
Similar Items
-
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
by: Jiwon Shin, et al.
Published: (2023-05-01) -
Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia
by: Olga S. Levchenkova, et al.
Published: (2023-03-01) -
Wiskott–Aldrich syndrome in a child presenting with macrothrombocytopenia
by: Jose Maria Bastida, et al.
Published: (2017-05-01) -
Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia
by: David J. Rabbolini, et al.
Published: (2018-11-01) -
Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
by: Ondine Walter, et al.
Published: (2022-11-01)